EUVIMEDEUVIMED entdecken
Open Access

Restoration of TFPI2 by LSD1 inhibition suppresses tumor progression and potentiates antitumor immunity in breast cancer

Tiezheng Gu, Shauna N Vasilatos, Jun Yin, Ye Qin, Lin Zhang, Nancy E Davidson, Yi Huang

Cancer Letters · 2024

DOI: 10.1016/j.canlet.2024.217182 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Letters, 2024. Verfasst von Tiezheng Gu und 6 weiteren Autor:innen. Beteiligte Einrichtung: UPMC Hillman Cancer Center, University of Pittsburgh, Pittsburgh, PA, USA. Hauptthemen laut MEDLINE: Histone Demethylases, Triple Negative Breast Neoplasms, Disease Progression, Glycoproteins. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, University of Iowa, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Histone lysine-specific demethylase 1 (LSD1) is frequently overexpressed in triple negative breast cancer (TNBC), which is associated with worse clinical outcome in TNBC patients. However, the underlying mechanisms by which LSD1 promotes TNBC progression remain to be identified. We recently established a genetically engineered murine model by crossing mammary gland conditional LSD1 knockout mice with Brca1-deficient mice to explore the role of LSD1 in TNBC pathogenesis. Cre-mediated Brca1 loss led to higher incidence of tumor formation in mouse mammary glands, which was hindered by concurrent depletion of LSD1, indicating a critical role of LSD1 in promoting Brca1-deficient tumors. We also demonstrated that the silencing of a tumor suppressor gene, Tissue Factor Pathway Inhibitor 2 (TFPI2), is functionally associated with LSD1-mediated TNBC progression. Mouse Brca1-deficient tumors exhibited elevated LSD1 expression and decreased TFPI2 level compared to normal mammary tissues. Analysis of TCGA database revealed that TFPI2 expression is significantly lower in aggressive ER-negative or basal-like BC. Restoration of TFPI2 through LSD1 inhibition increased H3K4me2 enrichment at the TFPI2 promoter, suppressed tumor progression, and enhanced antitumor efficacy of chemotherapeutic agent. Induction of TFPI2 by LSD1 ablation downregulates activity of matrix metalloproteinases (MMPs) that in turn increases the level of cytotoxic T lymphocyte attracting chemokines in tumor environment, leading to enhanced tumor infiltration of CD8+ T cells. Moreover, induction of TFPI2 potentiates antitumor effect of LSD1 inhibitor and immune checkpoint blockade in poorly immunogenic TNBC. Together, our study identifies previously unrecognized roles of TFPI2 in LSD1-mediated TNBC progression, therapeutic response, and immunogenic effects.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Histone DemethylasesTriple Negative Breast NeoplasmsDisease ProgressionGlycoproteinsAnimalsFemaleMiceHumansMice, KnockoutCell Line, TumorGene Expression Regulation, NeoplasticBRCA1 Protein

Stichwörter der Autor:innen

ChemotherapyImmunotherapyLSD1TFPI2TNBC

Substanzen

Histone Demethylasestissue-factor-pathway inhibitor 2GlycoproteinsKDM1A protein, humanKDM1a protein, mouseBRCA1 Protein

Autor:innen und Institutionen

  • UPMC Hillman Cancer Center, University of Pittsburgh, Pittsburgh, PA, USA.
  • UPMC Hillman Cancer Center, University of Pittsburgh, Pittsburgh, PA, USA; Department of Pharmacology & Chemical Biology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA; Department of Medicine, Univers…
  • Fred Hutchinson Cancer Center and University of Washington, Seattle, WA, USA.
  • UPMC Hillman Cancer Center, University of Pittsburgh, Pittsburgh, PA, USA; Department of Pharmacology & Chemical Biology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA; Department of Internal Medicine…

Förderung

  • NCI NIH HHS
  • University of Iowa
  • National Institutes of Health
  • Breast Cancer Research Foundation
  • Université Pierre et Marie Curie
  • Medical Center, University of Pittsburgh

Zitieren

APA

Gu, T., Vasilatos, S. N., Yin, J., Qin, Y., Zhang, L., Davidson, N. E., & Huang, Y. (2024). Restoration of TFPI2 by LSD1 inhibition suppresses tumor progression and potentiates antitumor immunity in breast cancer. Cancer Letters. https://doi.org/10.1016/j.canlet.2024.217182

Vancouver

Gu T, Vasilatos SN, Yin J, Qin Y, Zhang L, Davidson NE, et al. Restoration of TFPI2 by LSD1 inhibition suppresses tumor progression and potentiates antitumor immunity in breast cancer. Cancer Letters. 2024. doi:10.1016/j.canlet.2024.217182

BibTeX
@article{Gu2024,
  author = {Gu, Tiezheng and Vasilatos, Shauna N and Yin, Jun and Qin, Ye and Zhang, Lin and Davidson, Nancy E and Huang, Yi},
  title = {Restoration of TFPI2 by LSD1 inhibition suppresses tumor progression and potentiates antitumor immunity in breast cancer},
  journal = {Cancer Letters},
  year = {2024},
  doi = {10.1016/j.canlet.2024.217182}
}
Kostenlos starten →